Cardiovascular Diseases in the Elderly
Conditions
Interventions
Control (Standard EECP ):The Chongqing Pushikang Technology P-ECP/TI-S pneumatic external counterpulsation device was utilized. The initial cuff pressure was set at 0.018-0.045 MPa by an experienced t
Experimental (NHM-EECP ):Prior to each EECP session, patients were connected to a noninvasive hemodynamic monitor (employing a thoracic electrical bioimpedance-based device from OSYPKA, Germany). Foll
(b) Real-time cardiac index (CI) increased by =10% compared to the pre-treatment resting baseline value
(c) Absence of significant patient discomfort such as dizziness or chest pain. During therapy, real-time monitoring was performed. An automatic alarm would be triggered and the pressure would be reduc
Sponsors
The First Affiliated Hospital of Air Force Medical University
Eligibility
Sex/Gender
All
Age
80 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age = 80 years; 2. Patients with stable coronary artery disease accompanied by one of the following conditions: angina pectoris, chronic heart failure, status post percutaneous coronary intervention (PCI), or old myocardial infarction with evidence of myocardial ischemia; 3.Meeting the indications for Enhanced External Counterpulsation (EECP) therapy and having no contraindications; 4. Having provided written informed consent.
Exclusion criteria
Exclusion criteria: 1. Presence of absolute contraindications to Enhanced External Counterpulsation (EECP), including but not limited to: severe aortic valve insufficiency, active thrombophlebitis, deep vein thrombosis (DVT) of the lower extremities, severe aortic aneurysm, uncontrolled hypertension (blood pressure > 180/110 mmHg); 2. Presence of severe cardiac arrhythmias; 3. Limb deformities or severe peripheral arterial disease that would interfere with proper cuff application of the EECP device; 4.Cognitive impairment precluding cooperation with the assessment/treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiac Index (CI); | — |
Secondary
| Measure | Time frame |
|---|---|
| Left Ventricular Ejection Fraction (LVEF);Left Ventricular End-Diastolic Diameter (LVEDD);Left Ventricular End-Systolic Diameter (LVESD);6-Minute Walk Distance (6MWD);NYHA class;CCS class;Quality of sleep; Emotional state;Quality of life;Stroke volume;Cardiac output;Systemic Vascular Resistance;N-terminal pro-B-type natriuretic peptide( NT-proBNP); | — |
Countries
China
Contacts
Public ContactYingjun Gong
The First Affiliated Hospital of Air Force Medical University
Outcome results
None listed